The global Radiotherapy Market is estimated to be valued at US$ 7,078.91 million in 2022 and is expected to exhibit a CAGR of 6.8% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Radiotherapy refers to the use of high-energy radiation to destroy cancer cells and shrink tumors. The advantages of radiotherapy include targeted treatment, minimal invasiveness, and reduced side effects compared to other cancer treatment options. The need for effective and efficient cancer treatments, increasing prevalence of cancer, and advancements in radiotherapy technology are driving the growth of the radiotherapy market.
Market key trends:
One key trend in the radiotherapy market is the adoption of advanced image-guided radiotherapy (IGRT) systems. IGRT involves the use of real-time imaging techniques to precisely locate and deliver radiation to cancer cells. This technology enables accurate targeting of tumors and minimizes radiation exposure to surrounding healthy tissues. The rising demand for more precise and personalized cancer treatments is fueling the adoption of IGRT systems. Furthermore, the integration of IGRT with other advanced radiotherapy techniques, such as intensity-modulated radiation therapy (IMRT) and stereotactic radiosurgery (SRS), is further enhancing the efficacy of radiotherapy for various types of cancer. The growing adoption of IGRT systems is likely to drive the growth of the radiotherapy market in the coming years.
The radiotherapy market can be segmented based on type, application, and end user. In terms of type, external beam radiation therapy (EBRT) is expected to dominate the market during the forecast period. This is due to the increasing preference for non-invasive treatment options and advancements in technology, such as intensity-modulated radiation therapy (IMRT) and stereotactic radiosurgery (SRS), which improve the precision and effectiveness of EBRT. Additionally, EBRT is widely used for the treatment of various types of cancer, including breast, lung, and prostate cancer, further contributing to its dominance in the market.
The global Radiotherapy Market is expected to witness high growth, exhibiting a CAGR of 6.8% over the forecast period. This growth can be attributed to several factors. Firstly, there is a rising prevalence of cancer worldwide, leading to an increase in the demand for radiotherapy as a primary treatment or in combination with other therapies. Additionally, technological advancements in radiotherapy equipment and techniques, such as image-guided radiation therapy (IGRT) and proton therapy, are improving the accuracy and efficacy of treatment, further driving market growth.
In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the radiotherapy market. This can be attributed to the presence of a well-established healthcare infrastructure, high healthcare expenditure, and increasing prevalence of cancer in the region. Moreover, the availability of advanced radiotherapy technologies and a favorable reimbursement scenario for cancer treatments contribute to the dominance of North America in the market.
Key players operating in the radiotherapy market include Accuray Incorporated, Elekta, Isoray Inc., CIVCO, Hitachi, Ltd., Mevion Medical Systems, ProTom International, VIEWRAY TECHNOLOGIES, INC., Panacea Medical Technologies Pvt. Ltd., Optivus Proton Therapy, Inc., RefleXion, MacroMedics, Vision RT Ltd., and Qfix. These companies are focusing on technological advancements, collaborations, and mergers and acquisitions to strengthen their market position and expand their product portfolios. Overall, the radiotherapy market is characterized by intense competition among key players, driven by the increasing demand for advanced radiotherapy solutions.